![Timothy D. Ocain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy D. Ocain
No open positions remaining
Profile
Timothy D.
Ocain worked as Vice President-Inflammation Discovery at Millennium Pharmaceuticals, Inc. from 1998 to 2006.
He then worked as Senior VP-New Product Strategy & Development at Enanta Pharmaceuticals, Inc. before becoming Senior Vice President-Research & Development at Seaside Therapeutics LLC from 2006 to 2009.
Ocain holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of Wisconsin-Eau Claire.
Former positions of Timothy D. Ocain
| Companies | Position | End |
|---|---|---|
Seaside Therapeutics LLC
 Seaside Therapeutics LLC Medical DistributorsDistribution Services Develops drug treatments to correct or improve the course of fragile x syndrome | Chief Tech/Sci/R&D Officer | 31/12/2008 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 31/12/2005 |
| ENANTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Timothy D. Ocain
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Seaside Therapeutics LLC
Seaside Therapeutics LLC Medical DistributorsDistribution Services Develops drug treatments to correct or improve the course of fragile x syndrome | Distribution Services |
University of Wisconsin-Eau Claire
 University of Wisconsin-Eau Claire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Timothy D. Ocain
Choose MarketScreener 
